Association Study of FOS–Like Antigen-2 Promoter Polymorphisms With Papillary Thyroid Cancer in Korean Population

다국어 초록 (Multilingual Abstract)

Objectives. FOS–like antigen-2 (FOSL-2), a member of the FOS gene family, encode leucine zipper proteins that can het- erodimerize with proteins of Jun family. Thus, activating protein (AP)-1 transcription factor is formed, has a crucial role in proliferation, differentiation and apoptosis of normal tissue as well as oncogenic transformation and progression. We performed an association study of single nucleotide polymorphisms (SNPs) in the FOSL-2 with papillary thyroid can- cer (PTC). We also estimated the relationships between the SNPs and the clinicopathologic characteristics of PTC.
Methods. One promoter SNPs (rs925255) of FOSL-2 gene were genotyped with direct sequencing method in 94 PTC and 213 controls. PTC patients were dichotomized and compared with respect to clinical parameters of PTC. Genetic data were analyzed using Helixtree, SNPAnalyzer, SNPStats. Multivariate logistic regression analysis was fulfilled to evaluate the genetic effect with adjustment for age and sex.
Results. SNP (rs925255) in FOSL-2 showed a significant association (codominant 1 model [G/G vs. A/G]: odds ratio [OR], 0.531, 95% confidence interval [CI], 0.293 to 0.96, P=0.036; dominant model: OR, 0.50, 95% CI, 0.28 to 0.89, P= 0.015) with PTC. The frequency of allele G in rs925255 was also significantly associated with PTC (OR, 0.59; 95% CI, 0.34 to 0.91; P=0.02). But we fail to prove significant association between this polymorphism (rs925255) and clinico-pathological parameters.
Conclusion. Our findings suggest that the rs925255 SNP and its allele G show significant association with the PTC in Ko- rean population.

참고문헌 (Reference)

1 Smith M, "Tissue-specific transgenic knockdown of Fos-related antigen 2 (Fra-2) expression mediated by dominant negative Fra-2" 21 (21): 3704-3713, 2001

2 Baverstock K, "Thyroid cancer after Chernobyl" 359 (359): 21-22, 1992

3 Ozgen AG, "The (-174) G/C polymorphism in the interleukin-6 gene is associated with risk of papillary thyroid carcinoma in Turkish patients" 32 (32): 491-494, 2009

4 Goldgar DE, "Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands" 86 (86): 1600-1608, 1994

5 Milde-Langosch K, "Role of Fra-2 in breast cancer: influence on tumor cell invasion and motility" 107 (107): 337-347, 2008

6 Siraj AK, "RAD52 polymorphisms contribute to the development of papillary thyroid cancer susceptibility in Middle Eastern population" 31 (31): 893-899, 2008

7 Bakiri L, "Promoter specificity and biological activity of tethered AP-1 dimers" 22 (22): 4952-4964, 2002

8 DeLellis RA, "Pathology and genetics of thyroid carcinoma" 94 (94): 662-669, 2006

9 Zitzelsberger H, "Molecular rearrangements in papillary thyroid carcinomas" 411 (411): 301-308, 2010

10 Handkiewicz-Junak D, "Molecular prognostic markers in papillary and follicular thyroid cancer: current status and future directions" 322 (322): 8-28, 2010

11 Erdogan M, "Interleukin-10 gene polymorphism in patients with papillary thyroid cancer in Turkish population" 31 (31): 750-754, 2008

12 Ministry for Health, Welfare and Family Affairs, "Incidence rates of cancer"

13 Murakami M, "Fra-2-positive autoregulatory loop triggered by mitogen-activated protein kinase (MAPK) and Fra-2 phosphorylation sites by MAPK" 10 (10): 333-342, 1999

14 Young MR, "Fra-1 a target for cancer prevention or intervention" 379 : 1-11, 2006

15 Chiappetta G, "FRA-1 expression in hyperplastic and neoplastic thyroid diseases" 6 (6): 4300-4306, 2000

16 Czene K, "Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish Family-Cancer Database" 99 (99): 260-266, 2002

17 Eun YG, "Associations between promoter polymorphism -106A/G of interleukin-11 receptor alpha and papillary thyroid cancer in Korean population" 151 (151): 323-329, 2012

18 Rebai M, "Association of polymorphisms in estrogen and thyroid hormone receptors with thyroid cancer risk" 29 (29): 113-118, 2009

19 Dardano A, "1513A>C polymorphism in the P2X7 receptor gene in patients with papillary thyroid cancer: correlation with histological variants and clinical parameters" 94 (94): 695-698, 2009